세계의 베타 글루칸 시장 예측(-2029년) : 카테고리별, 원료별, 용도별, 유형별, 지역별
Beta-Glucan Market by Category (Soluble, Insoluble), Source (Cereal & Grains, Mushroom, Yeast, Seaweed), Application (Food & Beverage, Dietary Supplement, Personal Care, Cosmetics, Pharmaceutical, Animal Feed), Type and Region - Global Forecast to 2029
상품코드:1473658
리서치사:MarketsandMarkets
발행일:2024년 04월
페이지 정보:영문 323 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 베타 글루칸 시장 규모는 2024년 5억 4,200만 달러에서 예측 기간 중 8.1%의 CAGR로 추이하며, 2029년에는 8억 달러 규모로 성장할 것으로 예측됩니다.
식품 및 음료에서 천연 첨가제 및 클린 라벨 첨가제에 대한 소비자 선호도가 높아지고 있는 것 등 몇개의 요인이 이 시장의 성장을 촉진하고 있습니다. 건강에 대한 관심이 높아짐에 따라 자연적이고 건강한 것으로 인식되는 제품에 대한 수요가 증가하고 있습니다. 귀리, 보리, 버섯 등 다양한 식품에 함유된 수용성 식이섬유인 베타글루칸은 이러한 추세에 부합하는 식품입니다. 베타글루칸은 천연 첨가제로서 기능적 이점뿐만 아니라 다양한 식품 및 음료 제품에 사용할 수 있는 매력적인 소재입니다.
조사 범위
조사 대상년
2024-2029년
기준년
2023년
예측 기간
2024-2029년
검토 단위
금액(달러)·수량(톤)
부문별
원료·용도·카테고리·유형·추출 방법(정성)·지역별
대상 지역
북미·유럽·아시아태평양·남미·기타 지역
소비자들 사이에서 고섬유질 식단에 대한 인식과 채택이 증가하고 있습니다. 고섬유질 식단은 소화기 건강 개선, 체중 관리 개선, 심장병 및 당뇨병과 같은 만성질환의 위험 감소 등 다양한 건강상의 이점을 제공하는 것으로 알려져 있습니다. 수용성 식이섬유인 베타글루칸은 콜레스테롤 수치를 낮추고 심장 건강을 개선하는 것으로 밝혀져 건강 지향적인 소비자들이 주목하고 있는 성분입니다.
곡물 부문은 2024년에 가장 큰 점유율을 차지할 것으로 예상됩니다.
곡물은 다른 많은 식품에 비해 베타글루칸 함량이 높은 것으로 알려져 있습니다. 특히 귀리와 보리는 베타글루칸이 풍부하며, 귀리는 베타글루칸이 가장 풍부한 식품 중 하나로 꼽힙니다. 곡류에 함유된 베타글루칸은 보통 혼합 결합형이며, 면역 조절 및 콜레스테롤 저하 등 건강에 유익한 효과를 나타냅니다. 최근 베네오가 2023년 7월 출시한 보리 베타글루칸 원료인 Orafti B-Fit은 베타글루칸과 그 건강 효과에 대한 인식이 높아짐에 따라 업계가 어떻게 대응하고 있는지를 잘 보여주는 사례입니다. 대한 업계의 대응을 보여주는 사례입니다. Beneo의 Orafti B-Fit은 심장 건강 및 혈당 관리 개선과 같은 건강상의 이점을 제공할 뿐만 아니라, 식품 제조업체들에게 영양 제품을 만들 수 있는 매력적인 원료를 제공합니다.에 대한 수요 증가에 적극적으로 대응하고 있는 광범위한 추세의 일환입니다. 이러한 노력은 영양과 건강을 연결하고 기능적이고 건강 증진에 도움이 되는 식품에 대한 소비자의 요구에 부응하기 위한 업계의 노력을 보여줍니다.
카테고리별로는 수용성 베타글루칸 부문이 예측 기간 중 시장을 지배할 것으로 예상됩니다.
수용성 베타글루칸은 귀리, 보리, 버섯과 같은 식품에 존재하는 수용성 식이섬유의 일종으로 다양한 건강상의 이점을 제공합니다. 여기에는 콜레스테롤 감소, 면역 반응 강화, 특정 암 발생 가능성 감소 등이 포함됩니다.
수용성 베타글루칸에 대한 관심이 높아지는 이유는 건강 증진 효과를 강조하는 연구 결과가 잇따라 발표되고 있기 때문입니다. 2020년 Nutrients 저널에 발표된 연구에 따르면 귀리, 보리 등의 베타글루칸을 식단에 포함시키면 심장병 위험의 주요 지표인 총 콜레스테롤과 LDL 콜레스테롤을 모두 낮출 수 있다고 합니다. 콜레스테롤과 LDL 콜레스테롤을 모두 낮추는 것으로 나타났습니다. 또한 이 연구는 베타글루칸이 염증을 억제하고 내피 기능을 향상시키는 등 심혈관계와 관련된 다른 이점도 제시했습니다.
북미는 식생활의 변화로 인해 시장에서 압도적인 위치를 차지하고 있습니다.
북미 베타글루칸 시장은 다양한 제품에 대한 다각적인 응용과 관련 건강 효과로 인해 강력한 성장세를 보이고 있으며, Cargill(미국), Millipore Sigma(독일), Lesaffre(프랑스) 등 주요 기업은 증점제, 지방 대체제, 식이섬유, 저콜레스테롤혈증 치료제 등 식품 및 음료 산업에서 베타글루칸의 적용을 확대하기 위한 기술 혁신을 추진하고 있습니다. 저콜레스테롤혈증 치료제 등 식품 및 음료 산업에서 베타글루칸의 용도를 확대하기 위해 기술 혁신을 활용하고 있습니다. 이러한 발전은 이 지역 시장 성장을 가속할 것으로 예상됩니다.
세계의 베타 글루칸 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회의 분석, 기술·특허의 동향, 법규제 환경, 시장 규모의 추이·예측, 각종 구분·지역별 상세 분석, 경쟁 구도, 주요 기업의 개요 등을 정리하여 전해드립니다.
The beta-glucan market is on a trajectory to witness substantial growth, with its value expected to soar from USD 542 million in 2024 to an estimated USD 800 million by 2029. This expansion represents a healthy CAGR of 8.1% throughout the projected period. Several key factors are fueling this upward trend, there is a growing consumer preference for natural and clean-label additives in food and beverages. As people become more health-conscious, there's an increasing demand for products that are perceived as natural and wholesome. Beta-glucan, which is a soluble fiber found in various sources such as oats, barley, and mushrooms, fits into this trend perfectly. It not only acts as a natural additive but also offers functional benefits, making it attractive for use in a wide range of food and beverage products.
Scope of the Report
Years Considered for the Study
2024-2029
Base Year
2023
Forecast Period
2024-2029
Units Considered
Value (USD), Volume (Ton)
Segments
By Source, by Application, by Category, by Type, by Extraction method (Qualitative) And Region
Regions covered
North America, Europe, Asia Pacific, South America, and RoW
There is a rising awareness and adoption of high-fiber diets among consumers. High-fiber diets are known to offer a myriad of health benefits, including improved digestive health, better weight management, and reduced risk of chronic diseases like heart disease and diabetes. Beta-glucan, being a soluble fiber, has been shown to help lower cholesterol levels and improve heart health, making it a sought-after ingredient for health-conscious consumers.
"The segment cereals & grains is expected to account for the largest share in 2024."
Cereals and grains are recognized for their elevated levels of beta-glucan compared to many other food types. Notably, oats and barley are particularly rich in beta-glucan, with oats standing out as one of the most abundant dietary sources. The beta-glucans found in cereals and grains are usually of the mixed-linkage variety, which has demonstrated beneficial health effects, including immune-modulating and cholesterol-reducing properties. Due to their high beta-glucan content, cereals and grains are sought-after sources for obtaining this advantageous compound. Beneo's recent launch of Orafti B-Fit in July 2023, a barley beta-glucans ingredient, exemplifies the industry's response to increasing awareness of beta-glucans and their health benefits. This innovative product not only offers significant health advantages like improving heart health and blood sugar management but also provides food manufacturers with an appealing ingredient for creating nutritional products. Beneo's introduction of Orafti B-Fit is part of a broader trend where companies are actively meeting the rising demand for beta-glucans by developing and launching new products. Such initiatives demonstrate the industry's commitment to connecting nutrition and health, addressing consumer needs for functional and health-promoting food options.
"The soluble beta-glucan segment is projected to dominate the market in the category segment during the forecast period."
Soluble beta-glucan, a form of soluble fiber present in foods like oats, barley, and mushrooms, offers a range of health advantages. These include lowering cholesterol, enhancing immune response, and potentially decreasing the likelihood of certain cancers.
The surging interest in soluble beta-glucan is fueled by an expanding body of research highlighting its health-promoting properties. A 2020 study featured in Nutrients found that incorporating beta-glucan from sources like oats and barley into one's diet can lead to reductions in both total and LDL cholesterol, key indicators of heart disease risk. Furthermore, the study suggested additional cardiovascular benefits associated with beta-glucan, such as diminishing inflammation and boosting endothelial function..
"Changes in dietary choices have positioned North America as a dominating region in the beta-glucan market."
The North American beta-glucan market is experiencing robust growth, driven by its multifaceted applications across various products and the associated health benefits. Leading market players, including Cargill (US), Millipore Sigma (Germany), and Lesaffre (France), are leveraging technological innovations to expand beta-glucan's use in the food and beverage industry, serving as thickening agents, fat substitutes, dietary fiber, and hypocholesterolemic agents. These advancements are anticipated to fuel market growth in the region.
In the US, consumer trends are shifting towards calorie-conscious choices, leading to a preference for low-calorie and low-fat food options. This change is not only influenced by a general health consciousness but also by the rising prevalence of obesity and cardiovascular diseases. Data from the CDC and the National Health and Nutrition Examination Survey (2021-2022) indicates that the obesity rate among adults in the US has surged to 42.4% between 2020 and 2021.
Furthermore, the escalating number of diabetes cases is reshaping dietary habits, with consumers increasingly seeking natural and low-calorie ingredients to manage their health. Given the significant diabetes prevalence in the US, where 38.4 million people, or 11.6% of the population, have diabetes and an additional 97.6 million adults have prediabetes, there is a growing demand for functional food ingredients like beta-glucan. Beta-glucan's potential benefits in managing blood sugar levels make it a particularly attractive option for diabetes patients and those at risk of developing the condition. As such, the changing dietary habits driven by the diabetes epidemic are expected to further propel the growth of the beta-glucan market in North America.
The break-up of the profile of primary participants in the beta-glucan market:
By Company Type: Tier 1 - 25%, Tier 2 - 45%, and Tier 3 - 30%
By Designation: CXO's - 20%, Managers - 50%, Executives- 30%
By Region: North America - 25%, Europe - 20%, Asia Pacific - 30%, South America - 15% and Rest of the World -10%
Prominent companies Tate & Lyle PLC (London), Kerry Group PLC (Ireland), DSM Firmenich (Switzerland), Merck (US), Kemin Industries (US), Alltech (US), AngelYeast Co., Ltd (China), Lallemand Inc. (Canada), Leiber (Germany), Lesaffre (France) Associated British Foods Plc (UK), Biorigin (Brazil), Ceapro Inc. (Canada), Specialty Biotech Co., Ltd. (US), Alltech (US), Garuda International Inc. (US), and Leiber (Germany).
Other players include VW-Ingredients (Netherlands), Super Beta Glucan(US), GlycaNova AS (Norway), NutriScience Innovations, LLC (US), Algalif Iceland hf. (Iceland), ABAC R&D (Switzerland), Natural Biologics (New Zealand), BENEO (Germany), L&P Food Ingredient Co., Ltd. (China), Beta Bio Technology sp. z o. o (Poland).
Research Coverage:
This research report categorizes the beta-glucan market by Source (Grains & Cereals, Mushrooms, Yeast, and Seaweed), Category (Soluble and Insoluble), Application (Food & Beverage, Personal Care, Pharmaceutical, Dietary Supplement and Animal Feed), Type ( {1,3} beta-glucan, {1,4} beta-glucan, {1,6} beta-glucan) and region (North America, Europe, Asia Pacific, South America, and Rest of the World). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the beta-glucan market. A detailed analysis of the key industry players has been done to provide insights into their business overview, key strategies, contracts, partnerships & agreements, new product launches, mergers & acquisitions, and recent developments associated with the beta-glucan market. Competitive analysis of upcoming startups in the de-oiled lecithin market ecosystem is covered in this report.
Reasons to buy this report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall beta-glucan market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
Analysis of key drivers (Increase in application of beta glucan in different industries), restraints (Inconsistency in regulatory norms governing beta-glucan), opportunities (Untapped beta-glucan applications), and challenges (Lack of consumer awareness) influencing the growth of the beta-glucan market.
Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the beta-glucan market.
Market Development: Comprehensive information about lucrative markets - the report analyses the beta-glucan market across varied regions.
Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the beta-glucan market.
Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players such as Tate & Lyle PLC (England), Kerry Group PLC (Ireland), dsm-Firmenich (Switzerland), Merck (Germany), among others in the beta-glucan market strategies. The report also helps stakeholders understand the beta-glucan market and provides them information on key market drivers, restraints, challenges, and opportunities.
TABLE OF CONTENTS
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKET SEGMENTATION
1.3.2 INCLUSIONS AND EXCLUSIONS
1.3.3 REGIONS COVERED
1.3.4 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
TABLE 1 USD EXCHANGE RATES, 2019-2023
1.5 UNIT CONSIDERED
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.7.1 IMPACT OF RECESSION
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 BETA-GLUCAN MARKET: RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Breakdown of primary profiles
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
11.3.1 GLUCAN FROM MUSHROOMS TO OFFER IMMUNE HEALTH BENEFITS AND IMPROVE SKIN HEALTH AND ANTI-INFLAMMATORY EFFECTS
TABLE 63 MUSHROOMS: BETA-GLUCAN MARKET, BY REGION, 2019-2023 (USD MILLION)
TABLE 64 MUSHROOMS: BETA-GLUCAN MARKET, BY REGION, 2024-2029 (USD MILLION)
TABLE 65 MUSHROOMS: BETA-GLUCAN MARKET, BY REGION, 2019-2023 (TONS)
TABLE 66 MUSHROOMS: BETA-GLUCAN MARKET, BY REGION, 2024-2029 (TONS)
11.4 YEAST
11.4.1 RISING PREVALENCE OF CHRONIC DISEASES, GROWING AWARENESS ABOUT HEALTH BENEFITS OF BETA-GLUCAN, AND SUPPORT OF GOVERNMENTS FOR RESEARCH AND DEVELOPMENT TO FOSTER MARKET
TABLE 67 YEAST: BETA-GLUCAN MARKET, BY REGION, 2019-2023 (USD MILLION)
TABLE 68 YEAST: BETA-GLUCAN MARKET, BY REGION, 2024-2029 (USD MILLION)
TABLE 69 YEAST: BETA-GLUCAN MARKET, BY REGION, 2019-2023 (TONS)
TABLE 70 YEAST: BETA-GLUCAN MARKET, BY REGION, 2024-2029 (TONS)
11.5 SEAWEED
11.5.1 SEAWEED-BASED BETA-GLUCAN TO BE USED IN COSMETIC AND PERSONAL CARE PRODUCTS FOR ITS MOISTURIZING, ANTI-INFLAMMATORY, AND ANTIOXIDANT PROPERTIES
TABLE 71 SEAWEED: BETA-GLUCAN MARKET, BY REGION, 2019-2023 (USD MILLION)
TABLE 72 SEAWEED: BETA-GLUCAN MARKET, BY REGION, 2024-2029 (USD MILLION)
FIGURE 51 ASIA PACIFIC COUNTRIES TO WITNESS SIGNIFICANT GROWTH IN BETA-GLUCAN MARKET, 2024-2029
TABLE 83 BETA-GLUCAN MARKET, BY REGION, 2019-2023 (USD MILLION)
TABLE 84 BETA-GLUCAN MARKET, BY REGION, 2024-2029 (USD MILLION)
TABLE 85 BETA-GLUCAN MARKET, BY REGION, 2019-2023 (TONS)
TABLE 86 BETA-GLUCAN MARKET, BY REGION, 2024-2029 (TONS)
13.2 NORTH AMERICA
FIGURE 52 NORTH AMERICA: BETA-GLUCAN MARKET SNAPSHOT
13.2.1 NORTH AMERICA: RECESSION IMPACT ANALYSIS
FIGURE 53 NORTH AMERICA: COUNTRY-LEVEL DATA OF INFLATION, 2017-2022
FIGURE 54 NORTH AMERICAN BETA-GLUCAN MARKET: RECESSION IMPACT ANALYSIS
TABLE 87 NORTH AMERICA: BETA-GLUCAN MARKET, BY COUNTRY, 2019-2023 (USD MILLION)
TABLE 88 NORTH AMERICA: BETA-GLUCAN MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
TABLE 89 NORTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2019-2023 (USD MILLION)
TABLE 90 NORTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2024-2029 (USD MILLION)
TABLE 91 NORTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2019-2023 (TONS)
TABLE 92 NORTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2024-2029 (TONS)
TABLE 93 NORTH AMERICA: BETA-GLUCAN MARKET, BY CATEGORY, 2019-2023 (USD MILLION)
TABLE 94 NORTH AMERICA: BETA-GLUCAN MARKET, BY CATEGORY, 2024-2029 (USD MILLION)
TABLE 95 NORTH AMERICA: BETA-GLUCAN MARKET, BY TYPE, 2019-2023 (USD MILLION)
TABLE 96 NORTH AMERICA: BETA-GLUCAN MARKET, BY TYPE, 2024-2029 (USD MILLION)
TABLE 97 NORTH AMERICA: BETA-GLUCAN MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
TABLE 98 NORTH AMERICA: BETA-GLUCAN MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
TABLE 99 NORTH AMERICA: BETA-GLUCAN PERSONAL CARE MARKET, BY FORM, 2019-2023 (USD MILLION)
TABLE 100 NORTH AMERICA: BETA-GLUCAN PERSONAL CARE MARKET, BY FORM, 2024-2029 (USD MILLION)
TABLE 101 NORTH AMERICA: BETA-GLUCAN PERSONAL CARE MARKET, BY FUNCTIONALITY, 2019-2023 (USD MILLION)
TABLE 102 NORTH AMERICA: BETA-GLUCAN PERSONAL CARE MARKET, BY FUNCTIONALITY, 2024-2029 (USD MILLION)
TABLE 103 NORTH AMERICA: BETA-GLUCAN COSMETICS MARKET, BY FORM, 2019-2023 (USD MILLION)
TABLE 104 NORTH AMERICA: BETA-GLUCAN COSMETICS MARKET, BY FORM, 2024-2029 (USD MILLION)
TABLE 105 NORTH AMERICA: BETA-GLUCAN COSMETICS MARKET, BY FUNCTIONALITY, 2019-2023 (USD MILLION)
TABLE 106 NORTH AMERICA: BETA-GLUCAN COSMETICS MARKET, BY FUNCTIONALITY, 2024-2029 (USD MILLION)
TABLE 107 NORTH AMERICA: BETA-GLUCAN ANIMAL FEED MARKET, BY SUB-APPLICATION, 2019-2023 (USD MILLION)
TABLE 108 NORTH AMERICA: BETA-GLUCAN ANIMAL FEED MARKET, BY SUB-APPLICATION, 2024-2029 (USD MILLION)
13.2.2 US
13.2.2.1 Increasing number of product launches by food manufacturers to fuel demand for beta-glucan
TABLE 109 US: BETA-GLUCAN MARKET, BY CATEGORY, 2019-2023 (USD MILLION)
TABLE 110 US: BETA-GLUCAN MARKET, BY CATEGORY, 2024-2029 (USD MILLION)
TABLE 111 US: BETA-GLUCAN MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
TABLE 112 US: BETA-GLUCAN MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
13.2.3 CANADA
13.2.3.1 Government approvals and rising efforts from market players to accelerate market growth
TABLE 113 CANADA: BETA-GLUCAN MARKET, BY CATEGORY, 2019-2023 (USD MILLION)
TABLE 114 CANADA: BETA-GLUCAN MARKET, BY CATEGORY, 2024-2029 (USD MILLION)
TABLE 115 CANADA: BETA-GLUCAN MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
TABLE 116 CANADA: BETA-GLUCAN MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
13.2.4 MEXICO
13.2.4.1 Rise in chronic lifestyle diseases, demand for health-benefiting products, and government initiatives to promote healthy lifestyles to drive market
TABLE 117 MEXICO: BETA-GLUCAN MARKET, BY CATEGORY, 2019-2023 (USD MILLION)
TABLE 118 MEXICO: BETA-GLUCAN MARKET, BY CATEGORY, 2024-2029 (USD MILLION)
TABLE 119 MEXICO: BETA-GLUCAN MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
TABLE 120 MEXICO: BETA-GLUCAN MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
13.3 EUROPE
13.3.1 EUROPE: RECESSION IMPACT ANALYSIS
FIGURE 55 EUROPE: COUNTRY-LEVEL DATA FOR INFLATION, 2017-2022
FIGURE 56 EUROPEAN BETA-GLUCAN MARKET: RECESSION IMPACT ANALYSIS
TABLE 121 EUROPE: BETA-GLUCAN MARKET, BY COUNTRY, 2019-2023 (USD MILLION)
TABLE 122 EUROPE: BETA-GLUCAN MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
TABLE 123 EUROPE: BETA-GLUCAN MARKET, BY SOURCE, 2019-2023 (USD MILLION)
TABLE 124 EUROPE: BETA-GLUCAN MARKET, BY SOURCE, 2024-2029 (USD MILLION)
TABLE 125 EUROPE: BETA-GLUCAN MARKET, BY SOURCE, 2019-2023 (TONS)
TABLE 126 EUROPE: BETA-GLUCAN MARKET, BY SOURCE, 2024-2029 (TONS)
TABLE 127 EUROPE: BETA-GLUCAN MARKET, BY CATEGORY, 2019-2023 (USD MILLION)
TABLE 128 EUROPE: BETA-GLUCAN MARKET, BY CATEGORY, 2024-2029 (USD MILLION)
TABLE 129 EUROPE: BETA-GLUCAN MARKET, BY TYPE, 2019-2023 (USD MILLION)
TABLE 130 EUROPE: BETA-GLUCAN MARKET, BY TYPE, 2024-2029 (USD MILLION)
TABLE 131 EUROPE: BETA-GLUCAN MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
TABLE 132 EUROPE: BETA-GLUCAN MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
TABLE 133 EUROPE: BETA-GLUCAN PERSONAL CARE MARKET, BY FORM, 2019-2023 (USD MILLION)
TABLE 134 EUROPE: BETA-GLUCAN PERSONAL CARE MARKET, BY FORM, 2024-2029 (USD MILLION)
TABLE 135 EUROPE: BETA-GLUCAN PERSONAL CARE MARKET, BY FUNCTIONALITY, 2019-2023 (USD MILLION)
TABLE 136 EUROPE: BETA-GLUCAN PERSONAL CARE MARKET, BY FUNCTIONALITY, 2024-2029 (USD MILLION)
13.3.2.1 Inclination toward natural and organic foods and rising prevalence of health-related problems to propel market
TABLE 143 GERMANY: BETA-GLUCAN MARKET, BY CATEGORY, 2019-2023 (USD MILLION)
TABLE 144 GERMANY: BETA-GLUCAN MARKET, BY CATEGORY, 2024-2029 (USD MILLION)
TABLE 145 GERMANY: BETA-GLUCAN MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
TABLE 146 GERMANY: BETA-GLUCAN MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
13.3.3 FRANCE
13.3.3.1 Rising incidence of lifestyle diseases, growing demand for functional foods, and favorable government policies to drive market
TABLE 147 FRANCE: BETA-GLUCAN MARKET, BY CATEGORY, 2019-2023 (USD MILLION)
TABLE 148 FRANCE: BETA-GLUCAN MARKET, BY CATEGORY, 2024-2029 (USD MILLION)
TABLE 149 FRANCE: BETA-GLUCAN MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
TABLE 150 FRANCE: BETA-GLUCAN MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
13.3.4 UK
13.3.4.1 Rising demand for healthier and more sustainable products and government's focus on awareness programs to promote healthy diet to drive market
TABLE 151 UK: BETA-GLUCAN MARKET, BY CATEGORY, 2019-2023 (USD MILLION)
TABLE 152 UK: BETA-GLUCAN MARKET, BY CATEGORY, 2024-2029 (USD MILLION)
TABLE 153 UK: BETA-GLUCAN MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
TABLE 154 UK: BETA-GLUCAN MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
13.3.5 ITALY
13.3.5.1 Rising demand for health-enriching ingredients to prevent risk of chronic diseases to foster market growth
TABLE 155 ITALY: BETA-GLUCAN MARKET, BY CATEGORY, 2019-2023 (USD MILLION)
TABLE 156 ITALY: BETA-GLUCAN MARKET, BY CATEGORY, 2024-2029 (USD MILLION)
TABLE 157 ITALY: BETA-GLUCAN MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
TABLE 158 ITALY: BETA-GLUCAN MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
13.3.6 SPAIN
13.3.6.1 Rising export opportunities and need to optimize animal health to boost demand for beta-glucan
TABLE 159 SPAIN: BETA-GLUCAN MARKET, BY CATEGORY, 2019-2023 (USD MILLION)
TABLE 160 SPAIN: BETA-GLUCAN MARKET, BY CATEGORY, 2024-2029 (USD MILLION)
TABLE 161 SPAIN: BETA-GLUCAN MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
TABLE 162 SPAIN: BETA-GLUCAN MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
13.3.7 REST OF EUROPE
TABLE 163 REST OF EUROPE: BETA-GLUCAN MARKET, BY CATEGORY, 2019-2023 (USD MILLION)
TABLE 164 REST OF EUROPE: BETA-GLUCAN MARKET, BY CATEGORY, 2024-2029 (USD MILLION)
TABLE 165 REST OF EUROPE: BETA-GLUCAN MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
TABLE 166 REST OF EUROPE: BETA-GLUCAN MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
13.4 ASIA PACIFIC
FIGURE 57 ASIA PACIFIC: BETA-GLUCAN MARKET SNAPSHOT
13.4.1 ASIA PACIFIC: RECESSION IMPACT ANALYSIS
FIGURE 58 ASIA PACIFIC: KEY COUNTRY-WISE INFLATION RATES, 2017-2022
FIGURE 59 ASIA PACIFIC: RECESSION IMPACT ANALYSIS, 2023
TABLE 167 ASIA PACIFIC: BETA-GLUCAN MARKET, BY COUNTRY, 2019-2023 (USD MILLION)
TABLE 168 ASIA PACIFIC: BETA-GLUCAN MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
TABLE 169 ASIA PACIFIC: BETA-GLUCAN MARKET, BY SOURCE, 2019-2023 (USD MILLION)
TABLE 170 ASIA PACIFIC: BETA-GLUCAN MARKET, BY SOURCE, 2024-2029 (USD MILLION)
TABLE 171 ASIA PACIFIC: BETA-GLUCAN MARKET, BY SOURCE, 2019-2023 (TONS)
TABLE 172 ASIA PACIFIC: BETA-GLUCAN MARKET, BY SOURCE, 2024-2029 (TONS)
TABLE 173 ASIA PACIFIC: BETA-GLUCAN MARKET, BY CATEGORY, 2019-2023 (USD MILLION)
TABLE 174 ASIA PACIFIC: BETA-GLUCAN MARKET, BY CATEGORY, 2024-2029 (USD MILLION)
TABLE 175 ASIA PACIFIC: BETA-GLUCAN MARKET, BY TYPE, 2019-2023 (USD MILLION)
TABLE 176 ASIA PACIFIC: BETA-GLUCAN MARKET, BY TYPE, 2024-2029 (USD MILLION)
TABLE 177 ASIA PACIFIC: BETA-GLUCAN MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
TABLE 178 ASIA PACIFIC: BETA-GLUCAN MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
TABLE 179 ASIA PACIFIC: BETA-GLUCAN PERSONAL CARE MARKET, BY FORM, 2019-2023 (USD MILLION)
TABLE 180 ASIA PACIFIC: BETA-GLUCAN PERSONAL CARE MARKET, BY FORM, 2024-2029 (USD MILLION)
TABLE 181 ASIA PACIFIC: BETA-GLUCAN PERSONAL CARE MARKET, BY FUNCTIONALITY, 2019-2023 (USD MILLION)
TABLE 182 ASIA PACIFIC: BETA-GLUCAN PERSONAL CARE MARKET, BY FUNCTIONALITY, 2024-2029 (USD MILLION)
TABLE 183 ASIA PACIFIC: BETA-GLUCAN COSMETICS MARKET, BY FORM, 2019-2023 (USD MILLION)
TABLE 184 ASIA PACIFIC: BETA-GLUCAN COSMETICS MARKET, BY FORM, 2024-2029 (USD MILLION)
TABLE 185 ASIA PACIFIC: BETA-GLUCAN COSMETICS MARKET, BY FUNCTIONALITY, 2019-2023 (USD MILLION)
TABLE 186 ASIA PACIFIC: BETA-GLUCAN COSMETICS MARKET, BY FUNCTIONALITY, 2024-2029 (USD MILLION)
TABLE 187 ASIA PACIFIC: BETA-GLUCAN ANIMAL FEED MARKET, BY SUB-APPLICATION, 2019-2023 (USD MILLION)
TABLE 188 ASIA PACIFIC: BETA-GLUCAN ANIMAL FEED MARKET, BY SUB-APPLICATION, 2024-2029 (USD MILLION)
13.4.2 CHINA
13.4.2.1 Higher demand for high-quality processed foods and presence of major vendors to foster market growth
TABLE 189 CHINA: BETA-GLUCAN MARKET, BY CATEGORY, 2019-2023 (USD MILLION)
TABLE 190 CHINA: BETA-GLUCAN MARKET, BY CATEGORY, 2024-2029 (USD MILLION)
TABLE 191 CHINA: BETA-GLUCAN MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
TABLE 192 CHINA: BETA-GLUCAN MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
13.4.3 JAPAN
13.4.3.1 Rise in healthcare costs and higher life expectancy due to preventive healthcare measures to drive market
TABLE 193 JAPAN: BETA-GLUCAN MARKET, BY CATEGORY, 2019-2023 (USD MILLION)
TABLE 194 JAPAN: BETA-GLUCAN MARKET, BY CATEGORY, 2024-2029 (USD MILLION)
TABLE 195 JAPAN: BETA-GLUCAN MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
TABLE 196 JAPAN: BETA-GLUCAN MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
13.4.4 INDIA
13.4.4.1 Promotion of innovation and product development in food industry to fuel demand for beta-glucan
TABLE 197 INDIA: BETA-GLUCAN MARKET, BY CATEGORY, 2019-2023 (USD MILLION)
TABLE 198 INDIA: BETA-GLUCAN MARKET, BY CATEGORY, 2024-2029 (USD MILLION)
TABLE 199 INDIA: BETA-GLUCAN MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
TABLE 200 INDIA: BETA-GLUCAN MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
13.4.5 AUSTRALIA & NEW ZEALAND
13.4.5.1 Need to promote animal growth, boost immunity, and improve overall productivity to propel market
TABLE 201 AUSTRALIA & NEW ZEALAND: BETA-GLUCAN MARKET, BY CATEGORY, 2019-2023 (USD MILLION)
TABLE 202 AUSTRALIA & NEW ZEALAND: BETA-GLUCAN MARKET, BY CATEGORY, 2024-2029 (USD MILLION)
TABLE 203 AUSTRALIA & NEW ZEALAND: BETA-GLUCAN MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
TABLE 204 AUSTRALIA & NEW ZEALAND: BETA-GLUCAN MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
13.4.6 REST OF ASIA PACIFIC
TABLE 205 REST OF ASIA PACIFIC: BETA-GLUCAN MARKET, BY CATEGORY, 2019-2023 (USD MILLION)
TABLE 206 REST OF ASIA PACIFIC: BETA-GLUCAN MARKET, BY CATEGORY, 2024-2029 (USD MILLION)
TABLE 207 REST OF ASIA PACIFIC: BETA-GLUCAN MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
TABLE 208 REST OF ASIA PACIFIC: BETA-GLUCAN MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
13.5 SOUTH AMERICA
13.5.1 SOUTH AMERICA: RECESSION IMPACT ANALYSIS
FIGURE 60 SOUTH AMERICA: COUNTRY-LEVEL DATA FOR INFLATION, 2017-2022
FIGURE 61 SOUTH AMERICA BETA-GLUCAN MARKET: RECESSION IMPACT ANALYSIS
TABLE 209 SOUTH AMERICA: BETA-GLUCAN MARKET, BY COUNTRY, 2019-2023 (USD MILLION)
TABLE 210 SOUTH AMERICA: BETA-GLUCAN MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
TABLE 211 SOUTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2019-2023 (USD MILLION)
TABLE 212 SOUTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2024-2029 (USD MILLION)
TABLE 213 SOUTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2019-2023 (TONS)
TABLE 214 SOUTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2024-2029 (TONS)
TABLE 215 SOUTH AMERICA: BETA-GLUCAN MARKET, BY CATEGORY, 2019-2023 (USD MILLION)
TABLE 216 SOUTH AMERICA: BETA-GLUCAN MARKET, BY CATEGORY, 2024-2029 (USD MILLION)
TABLE 217 SOUTH AMERICA: BETA-GLUCAN MARKET, BY TYPE, 2019-2023 (USD MILLION)
TABLE 218 SOUTH AMERICA: BETA-GLUCAN MARKET, BY TYPE, 2024-2029 (USD MILLION)
TABLE 219 SOUTH AMERICA: BETA-GLUCAN MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
TABLE 220 SOUTH AMERICA: BETA-GLUCAN MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
TABLE 221 SOUTH AMERICA: BETA-GLUCAN PERSONAL CARE MARKET, BY FORM, 2019-2023 (USD MILLION)
TABLE 222 SOUTH AMERICA: BETA-GLUCAN PERSONAL CARE MARKET, BY FORM, 2024-2029 (USD MILLION)
TABLE 223 SOUTH AMERICA: BETA-GLUCAN PERSONAL CARE MARKET, BY FUNCTIONALITY, 2019-2023 (USD MILLION)
TABLE 224 SOUTH AMERICA: BETA-GLUCAN PERSONAL CARE MARKET, BY FUNCTIONALITY, 2024-2029 (USD MILLION)
TABLE 225 SOUTH AMERICA: BETA-GLUCAN COSMETICS MARKET, BY FORM, 2019-2023 (USD MILLION)
TABLE 226 SOUTH AMERICA: BETA-GLUCAN COSMETICS MARKET, BY FORM, 2024-2029 (USD MILLION)
TABLE 227 SOUTH AMERICA: BETA-GLUCAN COSMETICS MARKET, BY FUNCTIONALITY, 2019-2023 (USD MILLION)
TABLE 228 SOUTH AMERICA: BETA-GLUCAN COSMETICS MARKET, BY FUNCTIONALITY, 2024-2029 (USD MILLION)
TABLE 229 SOUTH AMERICA: BETA-GLUCAN ANIMAL FEED MARKET, BY SUB-APPLICATION, 2019-2023 (USD MILLION)
TABLE 230 SOUTH AMERICA: BETA-GLUCAN ANIMAL FEED MARKET, BY SUB-APPLICATION, 2024-2029 (USD MILLION)
13.5.2 BRAZIL
13.5.2.1 Rising geriatric population, surge in obesity levels, urbanization, and health consciousness to spur market growth
TABLE 231 BRAZIL: BETA-GLUCAN MARKET, BY CATEGORY, 2019-2023 (USD MILLION)
TABLE 232 BRAZIL: BETA-GLUCAN MARKET, BY CATEGORY, 2024-2029 (USD MILLION)
TABLE 233 BRAZIL: BETA-GLUCAN MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
TABLE 234 BRAZIL: BETA-GLUCAN MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
13.5.3 ARGENTINA
13.5.3.1 Need for reducing cholesterol levels and promoting digestion to fuel demand for oats-derived beta-glucan
TABLE 235 ARGENTINA: BETA-GLUCAN MARKET, BY CATEGORY, 2019-2023 (USD MILLION)
TABLE 236 ARGENTINA: BETA-GLUCAN MARKET, BY CATEGORY, 2024-2029 (USD MILLION)
TABLE 237 ARGENTINA: BETA-GLUCAN MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
TABLE 238 ARGENTINA: BETA-GLUCAN MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
13.5.4 REST OF SOUTH AMERICA
TABLE 239 REST OF SOUTH AMERICA: BETA-GLUCAN MARKET, BY CATEGORY, 2019-2023 (USD MILLION)
TABLE 240 REST OF SOUTH AMERICA: BETA-GLUCAN MARKET, BY CATEGORY, 2024-2029 (USD MILLION)
TABLE 241 REST OF SOUTH AMERICA: BETA-GLUCAN MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
TABLE 242 REST OF SOUTH AMERICA: BETA-GLUCAN MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
TABLE 344 L&P FOOD INGREDIENT CO., LTD: BUSINESS OVERVIEW
15.2.10 BETA BIO TECHNOLOGY SP. Z O. O.
TABLE 345 BETA BIO TECHNOLOGY SP. Z O. O. : BUSINESS OVERVIEW
15.3 PRODUCT-BASED COMPANIES
15.3.1 CARGILL, INCORPORATED
TABLE 346 CARGILL, INCORPORATED: BUSINESS OVERVIEW
15.3.2 INTERNATIONAL FLAVORS & FRAGRANCES, INC.
TABLE 347 INTERNATIONAL FLAVORS & FRAGRANCES, INC.: BUSINESS OVERVIEW
15.3.3 VIVESA HOLDING S.R.O
TABLE 348 VIVESA HOLDING S.R.O: BUSINESS OVERVIEW
15.3.4 ALERIS
TABLE 349 ALERIS: BUSINESS OVERVIEW
15.3.5 ICC
TABLE 350 ICC: BUSINESS OVERVIEW
15.3.6 PROSOL S.P.A.
TABLE 351 PROSOL S.P.A.: BUSINESS OVERVIEW
15.3.7 ABN APLICACIONES BIOLOGICAS A LA NUTRICION
TABLE 352 ABN APLICACIONES BIOLOGICAS A LA NUTRICION: BUSINESS OVERVIEW
15.3.8 EW NUTRITION
TABLE 353 EW NUTRITION: BUSINESS OVERVIEW
15.3.9 BIOCHEM ZUSATZSTOFFE HANDELS- UND PRODUKTIONSGESELLSCHAFT MBH
TABLE 354 BIOCHEM ZUSATZSTOFFE HANDELS- UND PRODUKTIONSGESELLSCHAFT MBH: BUSINESS OVERVIEW
15.3.10 MIBELLE BIOCHEMISTRY
TABLE 355 MIBELLE BIOCHEMISTRY: BUSINESS OVERVIEW
*Details on Business Overview, Products/Solutions Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
16 ADJACENT & RELATED MARKETS
16.1 INTRODUCTION
TABLE 356 ADJACENT MARKETS
16.2 STUDY LIMITATIONS
16.3 YEAST MARKET
16.3.1 MARKET DEFINITION
16.3.2 MARKET OVERVIEW
TABLE 357 YEAST MARKET, BY TYPE, 2019-2023 (USD MILLION)
TABLE 358 YEAST MARKET, BY TYPE, 2024-2029 (USD MILLION)
16.4 STARTER CULTURE MARKET
16.4.1 MARKET DEFINITION
16.4.2 MARKET OVERVIEW
TABLE 359 STARTER CULTURE MARKET, BY APPLICATION, 2017-2021 (USD MILLION)
TABLE 360 STARTER CULTURE MARKET, BY APPLICATION, 2022-2027 (USD MILLION)
